Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) b...

FDA Recall #D-0145-2021 — Class II — December 3, 2020

Recall #D-0145-2021 Date: December 3, 2020 Classification: Class II Status: Terminated

Product Description

Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-771-77

Reason for Recall

Failed Dissolution Specifications

Recalling Firm

Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

15,144 cartons

Distribution

Nationwide

Code Information

M915744 OCT 2021 M904770 FEB 2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated